olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

NDC 70436-014 · Slate Run Pharmaceuticals, LLC

Generic nameolmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE

Strength5; 12.5; 20 mg/1; mg/1; mg/1

Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]

Marketing categoryANDA

Packages

70436-014-04 — 30 TABLET, FILM COATED in 1 BOTTLE (70436-014-04)

70436-014-06 — 90 TABLET, FILM COATED in 1 BOTTLE (70436-014-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69315-155 — HYDROCHLOROTHIAZIDE, 69367-219 — Hydrochlorothiazide, 69584-021 — AMLODIPINE BESYLATE, 69584-022 — AMLODIPINE BESYLATE, 69584-023 — AMLODIPINE BESYLATE, 69584-361 — Hydrochlorothiazide, 69584-362 — Hydrochlorothiazide, 70010-187 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-188 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-189 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70436-015 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-016 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-017 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-018 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70518-0174 — Lisinopril and Hydrochlorothiazide, 70518-0196 — Lisinopril and Hydrochlorothiazide, 70518-0297 — AMLODIPINE BESYLATE, 70518-0382 — Lisinopril and Hydrochlorothiazide, 70518-0835 — AMLODIPINE BESYLATE, 70518-1343 — Olmesartan Medoxomil, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels